Table 2.
Demographic and clinical characteristics (n = 20).
| Age category, y, n (%) | |
| 10–14 | 8 (40%) |
| 15–19 | 12 (60%) |
| Sex, n (%) | |
| Male | 1 (5%) |
| Female | 19 (95%) |
| Race, n (%) | |
| White | 10 (50%) |
| Black | 4 (20%) |
| Hispanic | 3 (15%) |
| Asian | 3 (15%) |
| Pain duration, mo | 22 (16) |
| Pain in family history, n (%) | 12 (60%) |
| Parental divorce or strain, n (%) | 7 (35%) |
| Number of diagnostic tests | 1.6 (0.6) |
| Full school attendance unchanged academic performance, n (%) | 5 (25%) |
| WPI | 7 (1.4) |
| SSS | 12 (2.8) |
| Yunus criteria met, n (%) | 17 (85%) |
| Treatment modalities | 2.4 (0.99) |
| Functional restoration, mo | 8.6 (3.4) |
The data are presented as the mean (standard deviation) or n (%), as indicated. Type of testing each count as 1: labs, imaging, and dynamic testing. WPI: Widespread Pain Index; SSS: Symptom Severity Scale. Treatment modalities: medications∗physical therapy, cognitive therapy, injections, and acupuncture. ∗Duloxetine, pregabalin, gabapentin, milnacipran, low dose naltrexone, and birth control pill.